Propanc Biopharma公司已正式执行反向股票分割(并股)方案。此举旨在满足纳斯达克资本市场持续上市的最低股价要求,从而稳固其上市地位。同时,公司期望这一资本结构调整能为其既定的长期业务增长与拓展计划提供更坚实的基础。
Propanc Biopharma公司已正式执行反向股票分割(并股)方案。此举旨在满足纳斯达克资本市场持续上市的最低股价要求,从而稳固其上市地位。同时,公司期望这一资本结构调整能为其既定的长期业务增长与拓展计划提供更坚实的基础。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.